Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 70
Titolo Data di pubblicazione Autore(i) File
Management of multiple myeloma|Terapia del mieloma multiplo 1-gen-2005 Di Raimondo, F.; Pennisi, A.; Bari, A.; Fiumara, P.; Palumbo, G. A.
Introduction of Combined Chemotherapies Plus Rituximab (R) Has Improved Outcome of Previously Untreated and Relapsed Follicular Lymphoma (FL) Patients (pts).. 1-gen-2006 Sacchi, Stefano; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Luminari, Stefano; Federico, Massimo; Francesco, Angrilli; Marco, Lombardo; Chiara, Broglia; Giovanni, Quarta; Maura, Brugiatelli
Incidence and outcome of Myelodysplastic Syndromes in province of Modena 1-gen-2007 Bari, Alessia; Marcheselli, Raffaella; Ivan, Rashid; Goretta, Bonacorsi; Roberto, Marasca; Francesca, Giacobbi; Patrizia, Zucchini; Federico, Massimo; Sacchi, Stefano
Rituximab in combination with chemotherapy has improved survival of patients with follicular lymphoma 1-gen-2007 Sacchi, Stefano; Marcheselli, Luigi; Marcheselli, Raffaella; Bari, Alessia; Ferri, Paola
SECOND MALIGNANCIES AFTER TREATMENT FOR INDOLENT LYMPHOMA: A 16 YEARS FOLLOW-UP STUDY 1-gen-2007 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; M., Lombardo; G., Buda; A., Lazzaro; P., Gobbi; C., Stelitano; M., Brugiatelli
Incidence and outcome of chronic myeloproliferative disorders: A population-based study from a cancer registry in northern Italy 1-gen-2007 Bari, Alessia; Marcheselli, Raffaella; I., Rashid; G., Bonacorsi; O., Bonanno; P., Temperani; G., Leonardi; Federico, Massimo; Sacchi, Stefano
Secondary malignancies after treatment of aggressive non-Hodgkin lymphoma: A GISL cohort study on 1259 patients 1-gen-2007 Sacchi, Stefano; Luigi, Marcheselli; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Giovanni, Quarta; Nicola Di, Renzo; Alberto, Fragasso; Francesco, Angrilli; Federico, Massimo
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? 1-gen-2007 Di Raimondo, F; Caruso, L; Bonanno, G; Naso, P; Chiarenza, A; Fiumara, P; Bari, Alessia; Palumbo, Ga; Russo, A; Giustolisi, R.
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients 1-gen-2007 Sacchi, Stefano; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Luminari, Stefano; F., Angrilli; F., Merli; D., Vallisa; L., Baldini; M., Brugiatelli; I. L., Study Group
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 1-gen-2007 Luminari, Stefano; Cesaretti, Marina; I., Rashid; Mammi, Caterina; Montanini, Antonella; E., Barbolini; Bellei, Monica; E., Pennese; A., Sirotti; Marcheselli, Luigi; G., Partesotti; Bari, Alessia; Maiorana, Antonino; G., Bonacorsi; Federico, Massimo
: Late toxicity and quality of life (QOL) after treatment for Hodgkin disease (HD): A Gruppo Italiano Studio Linfomi (GISL) cohort study on 223 patients 1-gen-2008 M., Vigliotti; G., Abbadessa; G., Gentile; F., Gentile; C., Stelitano; G., Ianni; P., Gobbi; F., Valentino; F., Merli; E., Barbolini; E., Iannitto; E., Eliardo; A., Lazzaro; C., Mammi; Bari, Alessia; Marcheselli, Raffaella; Sacchi, Stefano
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Gobbi, Pg; Angrilli, F; Brugiatelli, M; Musto, P; Federico, Massimo
Treatment of patients with recurrent follicular lymphoma with rituximab in combination with fludarabine and cyclophosphamide 1-gen-2008 Sacchi, S.; Marcheselli, L; Marcheselli, R; Bari, A; Ciancia, O.
Anthracycline-Fludarabine Containing Regimens with or without Rituximab in the Treatment of Advanced Follicular Lymphoma Patients 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Pozzi, Samantha; Bari, Alessia; Luminari, Stefano; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini; M., Spriano; G., Caparrotti; M., Musso; G., Quarta; M., Brugiatelli
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study 1-gen-2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; Lombardo, M; Buda, G; Lazzaro, A; Gobbi, Pg; Stelitano, C; Morabito, F; Quarta, G; Brugiatelli, M.
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 1-gen-2008 Bari, Alessia; I., Rashid; Marcheselli, Raffaella; G., Bonacorsi; G., Leonardi; Marasca, Roberto; P., Zucchini; F., Giacobbi; Federico, Massimo; Sacchi, Stefano
VALIDATION OF ABSOLUTE LYMPHOCYTE COUNT / REVISED IPI (ALC/R-IPI) SCORE MODEL, AS A PROGNOSTIC INDEX FOR DIFFUSE LARGE-B-CELL LYMPHOMA IN RITUXIMAB ERA 1-gen-2009 F., Mendicino; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; S., Falorio; G., Polimeno; M. C., Cox
Second Malignancy After Treatment for Non-Hodgkin Lymphoma: a Systematic Review and a Meta-Analysis of Population-Based and Cohort Studies 1-gen-2009 Sacchi, Stefano; Pirani, Monica; Marcheselli, Luigi; Marcheselli, Raffaella; Bari, Alessia; C., Cirilli; Federico, Massimo
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. 1-gen-2009 Bari, Alessia; Marcheselli, Luigi; Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha; Ferri, Paola; Balleari, E; Musto, P; Neri, S; Aloe Spiriti, Ma; Cox, M. C.
A RANDOMIZED PHASE II STUDY (GISL - MM03 TRIAL) WITH ORAL MELPHALAN+ PREDNISONE (MP) VERSUS MELPHALAN, + PREDNISONE + THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 1-gen-2009 Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha; Bari, Alessia; O., Ciarcia; L., Masini; A., Lazzaro; F., Morabito; A., Fragasso; N., Di Renzo; G., Quarta; G., Buda; P., Musto; M. L., Vigliotti; A., Pastorini; M., Brugiatelli
Mostrati risultati da 1 a 20 di 70
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile